(Reuters) – Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related ...
Baxter International (NYSE:BAX) said it has re-started all of its peritoneal dialysis solutions manufacturing lines at its North Cove, N.C., plant, which was knocked offline by flooding from ...
O.M.A.R. S.r.l. Pharmaceutical Blister Solution, WEGO, Baxter, Fresenius Kabi, Renacon Pharma, Melson Medical, Tom Medical, Rockwell Medical, and TianJin NuoDe. The study provides an in-depth analysis ...
It is Baxter's biggest manufacturing site and is also the largest supplier of intravenous and peritoneal dialysis solutions to the US market. Now, the FDA has added three new products to its list ...
It follows the sale of Baxter's contract development and manufacturing organisation (CDMO) business BioPharma Solutions (BPS ... care business – spanning dialysis machines and related supplies ...
The FDA is alerting healthcare providers about a potential high-risk issue with certain Baxter Healthcare Solution Sets with Duo-Vent Spikes. Baxter has issued a recall for several lots of these ...
Baxter International has temporarily closed ... It is also the largest manufacturer of intravenous and peritoneal dialysis ...
The company, a major provider of fluids used for home dialysis, is aiming to “restore ... units will be imported over the coming weeks as Baxter and federal agencies try to keep hospitals ...
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion ...